These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1232534)
1. Three dose regimens of adriamycin for induction of remission in acute leukemia in children: a Southwest Oncology Group Study. Starling KA; Berry DH; Britton HA; Humphrey GB; Vats T; Ragab AH Med Pediatr Oncol; 1975; 1(3):271-6. PubMed ID: 1232534 [TBL] [Abstract][Full Text] [Related]
2. Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study. Ragab AH; Sutow WW; Komp DM; Starling KA; Lyon GM; George S Cancer; 1975 Oct; 36(4):1223-6. PubMed ID: 1058045 [TBL] [Abstract][Full Text] [Related]
3. Low-dose adriamycin remission maintenance for advanced acute lymphoblastic leukemia: a Southwest Oncology, Group study. Hvizdala E; Komp D; Ragab A; Crist W; Chu JY Med Pediatr Oncol; 1981; 9(5):477-82. PubMed ID: 7029239 [TBL] [Abstract][Full Text] [Related]
4. Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin. Preisler H; Bjornsson S; Henderson ES; Hryniuk W; Higby D; Freeman A; Naeher C Med Pediatr Oncol; 1979; 7(3):269-75. PubMed ID: 542191 [TBL] [Abstract][Full Text] [Related]
5. Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group Study. Schreiter SL; Amare M; Stuckey WJ; Oishi N; Saiki JH; Vial R; Pendleton O; Morrison FS Am J Clin Oncol; 1982 Dec; 5(6):641-3. PubMed ID: 7165007 [TBL] [Abstract][Full Text] [Related]
6. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia. Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute nonlymphoblastic leukemia in children with a multiple-drug protocol. Haghbin M; Murphy ML; Tan CT Cancer; 1977 Oct; 40(4):1417-21. PubMed ID: 907961 [TBL] [Abstract][Full Text] [Related]
9. [Adriamycin in the therapy of child leukemias and tumors]. Maas B; Ruhrmann G; Wilmanns W Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):390-2. PubMed ID: 4356422 [No Abstract] [Full Text] [Related]
10. Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: a Southwest Oncology Group study. Shaw MT; Raab SO Med Pediatr Oncol; 1977; 3(3):261-6. PubMed ID: 284167 [TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Preisler HD; Gessner T; Azarnia N; Bolanowska W; Epstein J; Early AP; D'Arrigo P; Vogler R; Winton L; Chervenik P Cancer Chemother Pharmacol; 1984; 12(2):125-30. PubMed ID: 6697426 [TBL] [Abstract][Full Text] [Related]
12. Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients. Faulk WP; Taylor CG; Yeh CJ; McIntyre JA Mol Biother; 1990 Mar; 2(1):57-60. PubMed ID: 2334538 [TBL] [Abstract][Full Text] [Related]
13. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021 [TBL] [Abstract][Full Text] [Related]
14. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response. Kremer WB; Vogler WR; Chan YK Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365 [TBL] [Abstract][Full Text] [Related]